These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21615321)

  • 1. Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study.
    Barrios V; Llisterri JL; Escobar C; Alfaro P; Colado F; Ridocci F; Matali A
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):579-85. PubMed ID: 21615321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
    Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
    Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care.
    Nielsen OW; Cowburn PJ; Sajadieh A; Morton JJ; Dargie H; McDonagh T
    Eur J Heart Fail; 2007 Dec; 9(12):1178-85. PubMed ID: 18062902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients.
    Hildebrandt P; Collinson PO
    Am J Cardiol; 2008 Feb; 101(3A):25-8. PubMed ID: 18243854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.
    Lokuge A; Lam L; Cameron P; Krum H; de Villiers S; Bystrzycki A; Naughton MT; Eccleston D; Flannery G; Federman J; Schneider HG
    Circ Heart Fail; 2010 Jan; 3(1):104-10. PubMed ID: 19933409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
    Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?
    Lewin J; Ledwidge M; O'Loughlin C; McNally C; McDonald K
    Eur J Heart Fail; 2005 Oct; 7(6):953-7. PubMed ID: 16227134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is B-type natriuretic peptide-guided heart failure management cost-effective?
    Morimoto T; Hayashino Y; Shimbo T; Izumi T; Fukui T
    Int J Cardiol; 2004 Aug; 96(2):177-81. PubMed ID: 15262031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
    Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?
    Rodeheffer RJ
    J Am Coll Cardiol; 2004 Aug; 44(4):740-9. PubMed ID: 15312852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.